September 2020

Science

British Journal of Biomedical Science: Issue 3 2020 - a synopsis

Deputy Editor Guy Orchard provides a brief glimpse of the articles on offer in the third issue of the year.

Molecular Pathology & Genomics
Science

Reporting in histopathology: some personal insights

The team at Leicester Royal Infirmary have collaborated on this article, which discusses their experiences of scientist reporting in histopathology.

Histopathology
Science

100 years of bacterial strains

Sarah Alexander and Ayuen Lual from the National Collection of Type Cultures look back over a century of providing authentic bacterial strains.

Microbiology & Virology
Science

Laboratory errors in transfusion 2020

Anne Lockhart, IBMS representative on the Serious Hazards of Transfusion (SHOT) steering group, explains the latest annual report.

Haematology & Transfusion Science
Science

The big question: "What are the chances of a COVID-19 vaccine by Christmas?"

Immunology
Science

One-to-one: COVID response controvery

We hear from Professor Sunetra Gupta – the theoretical epidemiologist who believes in herd immunity and doesn’t believe in the lockdown.

Immunology
Science

A history of Chinese medicine

Stephen Mortlock looks back over the medical history of one of the most ancient civilisations on earth.

Science

My Lab: A multi-disciplinary laboratory

Lynnette Garrett, Laboratory Medicine Quality Manager, gives a guided tour of the services at Swansea Bay University Health Board.

Clinical Chemistry
News

"Don't delay cancer treatment"

A European Society for Medical Oncology (ESMO) interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published.

Histopathology
News

Cystic fibrosis drug for COVID-19

Patients with COVID-19 will be given the cystic fibrosis drug Dornase alfa to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.

Microbiology & Virology
Resources

The organisation that delivers

After years of frustration, people are finally starting to understand the value of biomedical scientists.

Molecular Pathology & Genomics
Top